Protocols
Bladder
Adjuvant therapy for urothelial carcinoma using CISplatin and gemcitabine
Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Using Pembrolizumab
Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Using 6-Weekly Pembrolizumab
Palliative therapy for urothelial carcinoma using CISplatin and gemcitabine
Therapy for high risk superficial transitional cell bladder cancer using BCG
Palliative Therapy for BCG-Refractory Superficial High-Grade Transitional Cell Carcinoma Bladder with BCG and Interferon
Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Gemcitabine
Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Mitomycin
Treatment of Locally Advanced Bladder Cancer with Weekly CISplatin and Concurrent Radiation
Therapy for transitional cell cancers of the urothelium using Methotrexate, vinBLAstine, DOXOrubicin and CISplatin
Neo-Adjuvant Therapy for Urothelial Carcinoma Using CISplatin and Gemcitabine
Therapy for Non-Metastatic Castration Resistant Prostate Cancer Using Enzalutamide
Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Abiraterone and predniSONE
Treatment of Non- Metastatic Castration Resistant Prostate Cancer Using Apalutamide
Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Cabazitaxel and predniSONE
Palliative Therapy for Metastatic Hormone Refractory Prostate Cancer Using DOCEtaxel and predniSONE
First-Line Treatment of Castration Sensitive, Metastatic Prostate Cancer Using DOCEtaxel and Androgen Deprivation Therapy
Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Enzalutamide
Therapy for Prostate Cancer Using LHRH agonist (Goserelin, Leuprolide or Buserelin)
Therapy for Advanced Prostate Cancer Using LHRH antagonist Degarelix
Palliative therapy for hormone-refractory prostate cancer using mitoXANTRONE and predniSONE
Non-Steroidal Treatment of Prostate Cancer
Therapy for Metastatic Castration Resistant Prostate Cancer Using Radium-223
Curative Therapy for Germ Cell Cancer using Bleomycin, Etoposide and CISplatin
Therapy for nonseminoma germ cell cancer using Etoposide-CISplatin
Adjuvant therapy for stage I high risk seminoma using CARBOplatin
Palliative therapy for germ cell cancers using PACLitaxel and gemcitabine
Therapy for Relapsed Testicular Germ Cell cancer using PACLitaxel, lfosfamide and CISplatin (TIP)
Consolidation/ Salvage Treatment for Germ Cell Cancer Using VinBLAstine, CISplatin, Ifosfamide and Mesna
Consolidation and Salvage Therapy for Nonseminoma Using Etoposide, CISplatin, Ifosfamide, Mesna
Renal Cell Carcinoma Funding Algorithm
Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Ipilimumab and Nivolumab
Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Nivolumab
Treatment of Metastatic or Advanced Renal Cell Carcinoma Using 4-Weekly Nivolumab
Treatment of Metastatic Renal Cell Carcinoma Using Pembrolizumab and aXitinib
Therapy for Metastatic Renal Cell Carcinoma Using Axitinib
Therapy for Metastatic Renal Cell Carcinoma Using Cabozantinib
Therapy for Advanced Renal Cancer Using Everolimus
Palliative Therapy for Renal Cell Carcinoma Using Pazopanib
Palliative Therapy for Renal Cell Carcinoma Using SORAfenib
Palliative Therapy for Renal Cell Carcinoma Using SUNItinib
Therapy for Advanced Renal Cancer Using Temsirolimus
Palliative Therapy for Advanced Adrenal Cortical Cancer Using DOXOrubicin
Treatment of Metastatic Adrenocortical Cancer with Etoposide, DOXOrubicin, CISplatin and Mitotane
Combined Modality Therapy for Squamous Cell Cancer of the Genitourinary System Using Fluorouracil and CISplatin with Radiation
Treatment of Adrenal Cortical Cancer with Mitotane
Palliative Therapy of Extensive Stage Genitourinary Small Cell Tumours with a Platinum and Etoposide
Therapy of Genitourinary Small Cell Tumors with a Platin and Etoposide with Radiation
